Navigation Links
Donation opens new opportunities for more effective diabetes treatment
Date:2/6/2012

The Swedish medical university, Karolinska Institutet, has received a grant of 1.6 million Euro from the Stichting af Jochnick Foundation for research into the fundamental causes of diabetes. The grant will make it possible to use unique methods to study how the release of insulin is regulated in living organisms and this will create new opportunities for developing more effective drugs against diabetes.

Diabetes is an extremely common condition, and the number of people affected is increasing catastrophically all over the world. It has been calculated that in 2025, 300 million people will suffer from the disease, which not only causes major personal difficulties, but also places an enormous economic burden on the healthcare system. Professor Per-Olof Berggren at Karolinska Institutet has worked for many years mapping the signalling systems that regulate the release of insulin, and his research has led to several revolutionary discoveries.

"Diabetes is a global problem, and this means that it is vital that we understand the causes of the disease, in order to be able to offer more effective treatment. This is why we find it particularly important to support Professor Berggren's innovative and creative research", says Robert af Jochnick, who established the Jochnick Foundation together with his brother Jonas.

Diabetes arises when the body cannot regulate the sugar level in the bloodstream after eating. The level of sugar in the blood increases since there is insufficient insulin available, which is a hormone that normally reduces the blood sugar concentration and transports the sugar into cells. The support from the Jochnick Foundation will provide Professor Berggren and his group with the opportunity to use unique microscope technology to study, in detail and for long periods, how various signals control the release of insulin in living animals. This knowledge will not only be crucial to our understanding of the underlying causes of diab
'/>"/>

Contact: Per-Olof Berggren
per-olof.berggren@ki.se
46-707-295-731
Karolinska Institutet
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Risks of pregnancy via egg donation similar for women over age 50 as for younger women
2. Improving family consent in organ donation could save lives
3. Presumed Consent Wouldnt Boost U.S. Organ Donation: Study
4. Kidney Donation Doesnt Put Older Adults at Risk
5. Allowing Organ Donation by People With HIV Could Save Lives, Experts Say
6. Marrow Donation From Teenage Stranger Saves Mans Life
7. UC Irvine Medical Center is recognized for its commitment to organ donation
8. Breast center receives RI Pink Heals donation
9. Lack of trust in hospitals a major deterrent for blood donation among African-Americans
10. Stanford Who's Who & Anthony Casimano Make Donation to Help Support National Organization, CancerCare
11. Fresno Community Shows Appreciation to Veterans with Donation of Lifeclinic Health Station
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... sparrow to stray from her breeding partner and mate ... shows that sleeping around can be costly. , The ... Naturalist, found that offspring conceived outside sparrows, social ... within-pair offspring. The findings throw a monkey wrench into ... to cheat. , Most bird species display some form ...
(Date:5/22/2012)... developed a microfluidic chip to test for latent tuberculosis. ... more reliable than current testing for the disease. , ... real time," said Ying Liu, a research specialist working ... of Biomedical Engineering. , The team has already conducted ... the United States. , About one-third of the world,s ...
(Date:5/22/2012)... Law 42/2010, which extends the smoking ban to public ... of smokers (from 40.3% to 35.3%) and in consumption ... and women of all ages and occupations. , ... out by the Society of Prevention of Ibermutuamur (accidents ... the consumption of tobacco in the working populating during ...
(Date:5/22/2012)... TUESDAY, May 22 (HealthDay News) -- The United States ... 2011, according to a new report from the Governors ... from 50 states and the District of Columbia indicates ... the same number as in 2010. But ... in 2011, while rates rose in other states, according ...
(Date:5/22/2012)... TUESDAY, May 22 (HealthDay News) -- Hundreds of ... virus could develop potentially life-threatening liver complications over ... study. Researchers evaluated medical insurance claims data ... patients had advanced liver disease in 2008, and ... liver disease by 2015. The risk of ...
Breaking Medicine News(10 mins):Health News:For monogamous sparrows, it doesn't pay to stray (but they do it anyway) 2Health News:New TB test promises to be cheap and fast 2Health News:5 percent of workers gave up smoking when the anti-tobacco law took effect 2Health News:No Progress in Reducing U.S. Motorcycle Deaths: Report 2Health News:Hepatitis C Causing Liver Damage in Greater Numbers: Study 2
... will develop breast cancer in her life. But how much ... ,Breast cancer specialists from the University of Michigan Comprehensive Cancer ... necessary. And in some cases the fear paralyzes women and ... successful treatment. ,Here, experts debunk some of the ...
... dental care in United Kingdom, and a munificent grant of ... don’t figure anywhere on the NHS dental list. , ... the NHS registrations, down by a 42000 enrollments. This, notwithstanding ... dentists to ensure registrations are maintained. Yet, it has not ...
... death due to Japanese encephalitis, the death toll since ... ,According to the Additional Director (Health) Umakant ... been reported from several parts of the district since ... people were undergoing treatment at the BRD Medical College ...
... British Journal of Sports Medicine says that a woman's ... her fingers//. Researchers said that the finding could provide ... vulnerability to serious disease, intellectual ability, certain personality traits, ... in this area has so far focused exclusively on ...
... are investigating common painkiller drugs after researchers warned ... of heart attack//. ,The new data, ... the drugs doubled heart attack risk. ... such as diclofenac, etodolac, ibuprofen, indomethacin, ketoprofen, ketorolac, ...
... sites could face the risk of developing lung cancer although ... ,Researchers studied over 200 women under the age of ... healthy women in Teeside, northeast England, reported Newswise wire. ... this particular area of England, where heavy industries expanded rapidly ...
Other Medicine News:Health News:16 Common Myths About Breast Cancer 2Health News:16 Common Myths About Breast Cancer 3Health News:16 Common Myths About Breast Cancer 4Health News:16 Common Myths About Breast Cancer 5
(Date:5/22/2012)... MAY 22, 2012 ThermoGenesis Corp. (NASDAQ: ... for the processing, storage and administration of cell therapies, ... for its AXP® AutoXpress® Platform (AXP) used for the ... to initiate commercial activities in the country later this ... in the region,s cord blood market through our efforts ...
(Date:5/22/2012)... NEWTON, Mass., May 22, 2012  Halo ... novel therapeutics for rare fibrotic diseases, announced ... totaling $1.1 million from 12 not-for-profit foundations serving ... use the funds to expedite the phase ... candidate for Duchenne muscular dystrophy (DMD). HT-100, ...
(Date:5/22/2012)...  Systech International, a leading provider of Packaging ... integrity and authenticity, today announced that David F. ... Mr. Harty will be responsible for ... Cloud Products and Solutions, and aligning the company,s ... Harty has a unique perspective of the value ...
Breaking Medicine Technology:ThermoGenesis Announces Axp Approval In Thailand 2ThermoGenesis Announces Axp Approval In Thailand 3Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 2Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 3David F. Harty Joins Systech International as Vice President 2New White Paper Offers Model for Measuring Financial Impact of Reducing Toileting Related Falls in Healthcare Facilities 24747 1New White Paper Offers Model for Measuring Financial Impact of Reducing Toileting Related Falls in Healthcare Facilities 24747 2The CementBloc and Novartis Vaccines to Jointly Present Top Considerations in Interactive Selling at the 11th Annual iPharmaConnect 24744 1The CementBloc and Novartis Vaccines to Jointly Present Top Considerations in Interactive Selling at the 11th Annual iPharmaConnect 24744 2Prenatal exposure to combustion related pollutants and anxiety attention problems in young children 89857 1Prenatal exposure to combustion related pollutants and anxiety attention problems in young children 89857 2
... presents Phase 1 results demonstrating clinical activity ... previously treated with bortezomib, and provides an update on ... of perifosine in combination with dexamethasone, NEW YORK, ... today announced that positive phase 1 & phase 2 ...
... Data from Pivotal Study Show Bendamustine Produced a Significant ... in Overall Response Rate and Progression Free Survival, ... today that in a pivotal study of treatment-naive patients,with ... had better clinical outcomes compared to patients,treated with chlorambucil, ...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 7TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil 2TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil 3TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil 4TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil 5
For the quantitative determination of creatinine in serum. Fixed Time Reaction measured at 540 nm. Linearity: 25 mg/dl. Express Kit with Ready-to-Use Liquid....
Intended for the quantitative determination of magnesium in serum or plasma. Reaction: Endpoint. Wavelength: 520 nm. Linearity: 6.0 mg/dL (2.5 mmol/L)....
For the quantitative determination of total glucose in serum....
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L). Single vial, dry powder reagent....
Medicine Products: